{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:33:37Z","timestamp":1761597217631},"reference-count":27,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.vaccine.2010.07.027","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T10:49:03Z","timestamp":1279968543000},"page":"6621-6626","source":"Crossref","is-referenced-by-count":14,"title":["Vaccination against tick-borne encephalitis virus tests specific IgG production ability in patients under immunoglobulin substitution therapy"],"prefix":"10.1016","volume":"28","author":[{"given":"Markus G.","family":"Seidel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambis","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Heitger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"F\u00f6rster-Waldl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 (May)","key":"10.1016\/j.vaccine.2010.07.027_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.iac.2008.01.008","article-title":"Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency","volume":"28","author":"Berger","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4 (November)","key":"10.1016\/j.vaccine.2010.07.027_bib0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.iac.2008.06.004","article-title":"History of immunoglobulin replacement","volume":"28","author":"Eibl","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"Pt 2 (March)","key":"10.1016\/j.vaccine.2010.07.027_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1258\/acb.2008.008175","article-title":"Primary antibody deficiency syndromes","volume":"46","author":"Wood","year":"2009","journal-title":"Ann Clin Biochem"},{"issue":"10 (October)","key":"10.1016\/j.vaccine.2010.07.027_bib0020","first-page":"1405","article-title":"In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation","volume":"90","author":"Seidel","year":"2005","journal-title":"Haematologica"},{"issue":"3 (March)","key":"10.1016\/j.vaccine.2010.07.027_bib0025","first-page":"673","article-title":"Antibody to bacteriophage phi X 174 synthesized by cultured human peripheral blood lymphocytes","volume":"59","author":"Bohnsack","year":"1985","journal-title":"Clin Exp Immunol"},{"issue":"6 (December)","key":"10.1016\/j.vaccine.2010.07.027_bib0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0022-3476(96)70035-5","article-title":"Humoral immunity in steroid-dependent children with asthma and hypogammaglobulinemia","volume":"129","author":"Lack","year":"1996","journal-title":"J Pediatr"},{"issue":"12 (December)","key":"10.1016\/j.vaccine.2010.07.027_bib0035","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1172\/JCI106756","article-title":"Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases","volume":"50","author":"Ochs","year":"1971","journal-title":"J Clin Invest"},{"issue":"3 (September)","key":"10.1016\/j.vaccine.2010.07.027_bib0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel\u2013Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"3 (August 1)","key":"10.1016\/j.vaccine.2010.07.027_bib0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/519392","article-title":"West Nile virus neutralization by US plasma-derived immunoglobulin products","volume":"196","author":"Planitzer","year":"2007","journal-title":"J Infect Dis"},{"issue":"9627 (May 31)","key":"10.1016\/j.vaccine.2010.07.027_bib0050","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"issue":"21\u201322 (July 29)","key":"10.1016\/j.vaccine.2010.07.027_bib0055","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","article-title":"Persistence of protective immunity following vaccination against tick-borne encephalitis\u2013longer than expected?","volume":"22","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"27 (June 28)","key":"10.1016\/j.vaccine.2010.07.027_bib0060","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1016\/j.vaccine.2007.01.116","article-title":"Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up","volume":"25","author":"Rendi-Wagner","year":"2007","journal-title":"Vaccine"},{"issue":"Suppl. 1 (April 1)","key":"10.1016\/j.vaccine.2010.07.027_bib0065","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"50 (November 23)","key":"10.1016\/j.vaccine.2010.07.027_bib0070","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1016\/j.vaccine.2009.09.069","article-title":"Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs","volume":"27","author":"Stiasny","year":"2009","journal-title":"Vaccine"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.07.027_bib0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<102::AID-JMV16>3.0.CO;2-I","article-title":"Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis","volume":"48","author":"Holzmann","year":"1996","journal-title":"J Med Virol"},{"issue":"19 (October)","key":"10.1016\/j.vaccine.2010.07.027_bib0080","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol"},{"issue":"2 (August)","key":"10.1016\/j.vaccine.2010.07.027_bib0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2249.2006.03138.x","article-title":"Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists","volume":"145","author":"de Vries","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"2 (March)","key":"10.1016\/j.vaccine.2010.07.027_bib0090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CDLI.10.2.202-207.2003","article-title":"Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults","volume":"10","author":"Schauer","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2 (December 12)","key":"10.1016\/j.vaccine.2010.07.027_bib0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(03)00563-2","article-title":"Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity","volume":"22","author":"Ehrlich","year":"2003","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2010.07.027_bib0100","article-title":"Open-label, phase III clinical study of a modified tick-borne encephalitis vaccine: Evaluation of safety and immunogenicity in children and adolescents aged 1\u201315 years","volume":"296","author":"Poellabauera","year":"2006","journal-title":"IJMM"},{"issue":"3","key":"10.1016\/j.vaccine.2010.07.027_bib0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/088282403322396190","article-title":"Characterization of tick-borne encephalitis virus-specific human T lymphocyte responses by stimulation with structural TBEV proteins expressed in a recombinant baculovirus","volume":"16","author":"Gomez","year":"2003","journal-title":"Viral Immunol"},{"issue":"5 (January 30)","key":"10.1016\/j.vaccine.2010.07.027_bib0110","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.vaccine.2007.11.074","article-title":"Diminished response to tick-borne encephalitis vaccination in thymectomized children","volume":"26","author":"Prelog","year":"2008","journal-title":"Vaccine"},{"issue":"2 (August)","key":"10.1016\/j.vaccine.2010.07.027_bib0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood.V58.2.360.360","article-title":"Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment","volume":"58","author":"Witherspoon","year":"1981","journal-title":"Blood"},{"issue":"4 (April)","key":"10.1016\/j.vaccine.2010.07.027_bib0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin Chem"},{"issue":"July 29","key":"10.1016\/j.vaccine.2010.07.027_bib0125","article-title":"Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance","author":"Radosevich","year":"2009","journal-title":"Vox Sang"},{"issue":"9356","key":"10.1016\/j.vaccine.2010.07.027_bib0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(03)12457-9","article-title":"Serum test for assessment of patients with Bence Jones myeloma","volume":"361","author":"Bradwell","year":"2003","journal-title":"Lancet"},{"issue":"1 (October)","key":"10.1016\/j.vaccine.2010.07.027_bib0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2249.2009.03996.x","article-title":"Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production","volume":"158","author":"Heidt","year":"2009","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10010224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10010224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T13:17:43Z","timestamp":1591535863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10010224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":27,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0264410X10010224"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.07.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}